Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Budesonide, Formoterol Fumarate Drug Combination MeSH Descriptor Data 2026


MeSH Heading
Budesonide, Formoterol Fumarate Drug Combination
Tree Number(s)
D02.033.100.291.425.250
D02.092.063.291.425.250
D04.210.500.745.745.654.105.500
D26.310.348
Unique ID
D000069502
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069502
Scope Note
A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
Entry Term(s)
Budesonide Formoterol Drug Combination
Budesonide Formoterol Fumarate Drug Combination
Budesonide-Formoterol Drug Combination
Budesonide-Formoterol Fumarate Drug Combination
Symbicort
Pharm Action
Anti-Asthmatic Agents
Registry Numbers
0
Public MeSH Note
2016; BUDESONIDE, FORMOTEROL FUMARATE DRUG COMBINATION was indexed under ETHANOLAMINES and ADRENAL CORTEX HORMONES 2002-2015
History Note
2016 (2002)
Date Introduced
2016/01/01
Last Updated
2016/05/27
Budesonide, Formoterol Fumarate Drug Combination Preferred
Symbicort Narrower
page delivered in 0.156s